Controlling HCV in Switzerland: running against the clock

The use and reimbursement of direct-asting antivirals for all HCV-infected patients (regardless of the stage of disease) has been permitted in Switzerland since November 2017. Although at the outset treatment rates were high, they recently dropped dramatically.